Zocor curbs smoking-related lung damage, in rats

NEW YORK (Reuters Health) - Treatment with the cholesterol-lowering drug simvastatin, better known as Zocor, can inhibit the lung damage that occurs with smoking-induced chronic obstructive pulmonary disease (COPD), according to findings from an animal study.

Continue to Zocor curbs smoking-related lung damage, in rats on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz